Athira Pharma settlements

Athira Pharma was the subject of a securities class action settlement — formally titled Athira Pharma Securities Litigation — for investors who purchased or acquired the company's publicly traded common stock between September 17, 2020, and June 17, 2021. The total settlement fund was $10,000,000 in cash, available to class members who filed verified claims. The claim deadline of September 6, 2024, has passed; this verified record is maintained for reference.

Check what you may be owed Free · takes 20 seconds

Verified directory

1 verified record

Proof required

Athira Pharma Securities Litigation

Athira

Persons who purchased or otherwise acquired Athira Pharma, Inc. publicly traded common stock during the class period (September 17, 2020 through June 17, 2021) and were damaged thereby.

Claim window closed Official evidence on file

Related companies with verified settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record traces to an official source — and you open the official claim form yourself.

Check what you may be owed Browse all settlements